Neurologic Manifestations of SLE 1972
Nebraska State Journ Med, Oct 1972, pp 395., Aita,J., 1972
Modern Treatment of Parkinson's Disease
Excerpta Medica 2:1972 Aug., , 1972
Coagulation Defects Caused by Diphenylhydantoin
Neurol 22:1165-1171, Solomon,G.E.,et al, 1972
Modern Treatment of Parkinson's Disease
Excerpta Medica, 2:1971 Jun-Jul., , 1971
How to Treat Prolonged Epileptic Seizures
Consultant Sept 1971, p. 58., Livingston,S., 1971
Drug-Induced Neurologic Disorders in Childhood
Current Problems in Pediatrics 1:1, Schwartz,J., 1971
Drug-Induced Movement Disorders
Postgrad Med 180, 1971, Sept., North,R., 1971
Electroencephalogram in Anitconvulsant-Induce Folate Deficiency
BMJ 2:207, Dow,W., 1971
Manic Response to Levodopa Therapy
NEJM 285:788, Ryback,R.,et al, 1971
Axioms on Alcohol Withdrawal
Hosp Med 1970 Feb., Miller,B.H., 1970
Osteomalacia with Long-Term Anticonvulsant Therapy in Epilepsy
Disturbance of Calcium Metabolism by Anticonvulsant Drugs, Richens, BMJ 69 & 73, 1970 Oct., Dent,C.E.,et al, 1970
Monoamine Oxidase Inhibitor & L-Dopa
BMJ 3:388, Hunter,H.R.,et al, 1970
Restless Legs
Lead Article BMJ 758, Dec1970., , 1970
Petit Mal:A Critique Review
Neurol 17:197, Hanotia,P., 1969
Diphenylhydantoin Intoxication & Cerebrospinal Fluid Protein
Neurol 18:1009-1011, Rawson,M.D., 1968
Long-Term Follow-up of Patients with Petit Mal
Arch Neurol 16:595, Charlton,M.H.,et al, 1967
Epilepsy in Children
Current Therapy, 1966, p. 574., Scholl,M.L., 1966
Petit Mal Epilepsy
JAMA 194:113, Livingston,S.,et al, 1965
Diphenylhydantoin Activated Seizures
Neurol 15:716-722, Levy,L.L.,et al, 1965
Neurological Syndromes of SLE
Neurol l4:317, Fulton,W.,et al, 1964
Current Concepts in Therapy Treatment of Seizure Disorders
NEJM 269:1304, 1963; 269:1421963., Scholl,M.L., 1963
Unusual Brain Syndrome Seen with Diphenylhydantoin & Phenobarbitol
Am J Psych 120:282-283, Hoaken,P.C.S.,et al, 1963
The Diagnosis & Treatment of Seizures
Pediatr Clin North Am 9:353, Scholl,M.L., 1962
Dilantin Toxicity
Neurol 11:912-922, Roseman,E., 1961
Abducens Nerve Palsy in Dilantin Intoxication
J Pediatr 55:73-77, Manlapaz,J.S., 1959
A Study of Epilepsy in the Alcoholic Patient
Modern Neurology, Chap 42 p. 555., Victor,M., 1850
Alcoholism
Clin Neurol Chap 22 p. 1084, A. B. Baker Text Book of Neurology., Victor,M., 1850
Zorevunersen in Children and Adolescents with Dravet Syndrome
NEJM 394:969-982, Laux,L.,et al, 2026
Increased Prevalence of Nitrous Oxide-Induced Subacute Combined Degeneration of the Spinal Cord: Clinical and Imaging Findings
AJNR 47:513-520, Bruen,R.,et al, 2026
Tenecteplase for Acute Non-Large Vessel Occlusion 4.5 to 24 Hours After IschemicStroke, The OPTION Randomized Clinical Trial
JAMA doi:10.1001/JAMA.2026.0210, Ma,G.,et al, 2026
A Randomized Trial of Tenecteplase in Acute Central Retinal Artery Occlusion
NEJM 394:442-450, Ryan,S.J.,et al, 2026
Mucormycosis
NEJM 394:684-698, Kontoyiannia,D.P. & Walsh, T.J., 2026
A 41-Year-Old Man with Steroid-Responsive Hemiparesis
Neurol 106:e214088, Obaidi,Z.A.,et al, 2026
Reversible Leukoencephalopathy and Parkinsonism Due to CNS Involvement in Cryoglobulinemia
Neurol 106:e214622, German,A.,et al, 2026
Progressive Quadriparesis and Falls in a 66-Year-Old Man With Longstanding Human Immunodeficiency Virus
Neurol 106:e214621, Ong,B.A. & Carlson,A.K., 2026
Peripheral Neuropathy, A Review
JAMA 335:255-266, Mauermann,M.L. & Staff,N.P., 2026
A 67-Year-Old Man with Exercise Intolerance nd Progressive Weakness
Neurol 106:e214830, Gosset,A.,et al, 2026
Left Atrial Appendage Closure - Another Overused Method in Cardiology?
NEJM 394:1336-1338, Widimsky,P, 2026
Asundexian for Secondary Stroke Prevention
NEJM 394:1467-1479, 1540, Sharm,M.,et al, 2026
Large Language Model Performance and Clinical Reasoning Tasks
JAMA Netw Open 9:e264003, Rao,A.S.,et al, 2026
Bilateral Posterior Limb Internal Capsule T2 Hyperintensity and Severe Cerebellar Atrophy in 2 Lifelong Friends
Neurol 106:e218014, Inoue,H.,et al, 2026
Status Epilepticus After Carotid Endarterectomy:An Illustrative Case of Cerebral Hyperfusion Syndrome
Stroke 57:e188-191, Reuter,P.,et al, 2026
Glucagon-like Peptide-1 Receptor Agonists and Risk of Nonarteritic Anterior Ischemic Optic Neuropathy
Neurol 106:e214864, Dhivagaran,T.,et al, 2026
Endovascular Venous Sinus Stenting versus CSF Shunting for Idiopathic Intracranial Hypertssion:Nationwide Real-World Outcomes
AJNR 47:1238-1243, Chen,H.,et al, 2026
Cerebral Amyloid Angiopathy
NEJM 394:1836-1845, Greenberg,S.M., 2026
Iatrogenic Cerebral Amyloid Angiopathy after Cardiac Surgery, Two Case Reports
Neurol 106:e214819, Brunet de Courssou,J-B.,et al, 2026
Patterns and Factors Associated with Cerebral Infarction on MRi in Tuberculous Meningitis: Secondary Anlysis of the ACT-TBM Trial
Stroke 57:856-864, Chandu,M.,et al, 2026
Endovascular Therapy for Medium-Vessel Occlusion Stroke - Narrowing the Target Population
NEJM 394:1955-1957,1894, Ospel,J.M. & Hill, M.D., 2026
A Woman with Parkinson Disease, Dyskinesia, Rhadomyolysis, Subcutaneous Emphysema, and Pneumomediastinum
Neurol 106:e218064, Iqbal,M.M.,et al, 2026
Safety and Outcomes of Dibigatran Reversal with Idarucizumab Before IV Thrombolysis in Patients with Acute Ischemic Stroke
Neurol 106:e218012, Saflund,M.,et al, 2026